fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ESOT 2015: Tailor-made immunosuppression and post-transplant follow-up

Written by | 19 Nov 2015

by Maria Dalby: Advances in diagnostic techniques, genetic testing and immunosuppressive protocols allow clinicians to tailor interventions to the individual patient’s needs to a greater extent than in… read more.

Can asthma protect men from lethal prostate cancer?

Written by | 9 Oct 2015

Men with asthma are less likely to have aggressive prostate cancer or to die from the disease, according to a large, prospective cohort study published in the International… read more.

New age of genome editing could lead to cure for sickle cell anemia

Written by | 25 May 2015

UNSW Australia researchers have shown that changing just a single letter of the DNA of human red blood cells in the laboratory increases their production of oxygen-carrying haemoglobin… read more.

Why almost half of patients opt out of comprehensive cancer testing

Written by | 7 May 2015

Results highlight importance of pre-test counselling for at-risk patient populations.  Some at-risk patients opted out of comprehensive cancer gene screening when presented with the opportunity to be tested… read more.

Variance in BRCA1, BRCA2 mutations appear to be behind differing risks of breast and ovarian cancers

Written by | 16 Apr 2015

by Bruce Slyvester: Among a large group of women who carry disease-associated mutations in BRCA1 or BRCA2 genes, genetic mutations appear to be associated with significantly different risks of developing breast… read more.

Twin study link between back pain and depression

Written by | 23 Mar 2015

Genetic factors help to explain the commonly found association between low back pain and depression, suggests a large study of twins in the March issue of PAIN®.

ASH 2014 Video Interview by Esther Drain: Hodgkin Lymphoma: Prognosis and Therapy. Professor Ajay Gopal (University of Washington) discusses where we are with prognostic biomarkers and interim PET scans to direct therapy in HL

Written by | 18 Dec 2014

by Thomas R. Collins: Pursuit of useful risk biomarkers in HL still a work-in-progress. The quest for biomarkers in classic Hodgkin lymphoma, to determine which patients are at a… read more.

ESMO 2014 Report: Special symposium on ‘Advances in precision medicine of metastatic colorectal cancer’

Written by | 21 Nov 2014

by Denys Wheatley: There is some irony in the title of this symposium because medicine should always be as precise as it can, and advances are expected that… read more.

ESMO 2014 Report: Reclassifying cancer through genomics

Written by | 19 Nov 2014

Keynote lecture: Professor Sir Mike Stratton (Cambridge/Hinxton, UK) by Denys Wheatley.  On the thesis that the genetic understanding of cancer is fundamental to classifying and hence treating patients… read more.

ESMO 2014 Report: How to integrate genome sequencing data in oncology

Written by | 13 Nov 2014

by Denys Wheatley: Chaired by Atsushi Ohtsu and Jean-Yves Douillard, the first speaker Dr Kato (Japan) addressed the issue of the quest for different mutations in the hope… read more.

ESMO 2014 Report: Precision medicine: Panacea or false dawn?

Written by | 6 Nov 2014

Reports from the European Society for Medical Oncology 2014 Congress in Madrid by Denys Wheatley:  In his talk on Visualising the true spectrum of cancer- will we get… read more.

Study sheds light on asthma and respiratory viruses

Written by | 29 Oct 2014

People with asthma often have a hard time dealing with respiratory viruses such as the flu or the common cold, and researchers have struggled to explain why.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.